Results 11 to 20 of about 565 (123)

Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy. [PDF]

open access: yesAm J Hematol
American Journal of Hematology, Volume 100, Issue 9, Page 1651-1655, September 2025.
Origa R   +36 more
europepmc   +2 more sources

Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021. [PDF]

open access: yesCancer, 2023
Abstract Background The correlation between thalassemia and malignancies other than hepatocellular carcinoma (HCC) and the possible relationship between other hemoglobinopathies and tumor risk have been poorly evaluated. Methods Eight Italian specialized centers evaluated the incidence of malignant neoplasms in hemoglobinopathies as well as their sites
Origa R   +20 more
europepmc   +2 more sources

5613417 CO-TREATMENT OF ERYTHROID CELLS ISOLATED FROM Β039-THALASSEMIA PATIENTS WITH CRISPR-CAS9 GENE EDITING AND FETAL HEMOGLOBIN INDUCTION [PDF]

open access: yesHemasphere, 2023
HemaSphere, Volume 7, Issue S1, Page 41-41, April 2023.
M.L.P. Lipucci di Paola   +5 more
europepmc   +2 more sources

5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN [PDF]

open access: yesHemasphere, 2023
HemaSphere, Volume 7, Issue S1, Page 17-17, April 2023.
C.Z. Cristina Zuccato   +9 more
europepmc   +2 more sources

Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registry

open access: yesJournal of Cellular and Molecular Medicine, Volume 26, Issue 9, Page 2520-2528, May 2022., 2022
Abstract Although numerous patient‐specific co‐factors have been shown to be associated with worse outcomes in COVID‐19, the prognostic value of thalassaemic syndromes in COVID‐19 patients remains poorly understood. We studied the outcomes of 137 COVID‐19 patients with a history of transfusion‐dependent thalassaemia (TDT) and transfusion independent ...
Ibrahim El‐Battrawy   +49 more
wiley   +1 more source

P129: NARRATING SICKLE CELL DISEASE: THE EXPERIENCES OF PATIENTS AND CARGIVERS [PDF]

open access: yesHemasphere, 2022
HemaSphere, Volume 6, Issue S1, Page 32-32, January 2022.
De Franceschi L   +13 more
europepmc   +2 more sources

Il racconto della talassemia: Nelle mie vene e Paura di guarire

open access: yesRhesis, 2022
Il presente studio intende analizzare il racconto della talassemia in due testi contemporanei: Paura di guarire, di Ivano Argiolas (2021), e Nelle mie vene, di Flavio Soriga (2019).
Ramona Onnis
doaj   +1 more source

Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial

open access: yesTransfusion, Volume 61, Issue 6, Page 1729-1739, June 2021., 2021
Abstract Background The average hemoglobin content of red cell concentrates (RCC) varies depending on the method of preparation. Surprisingly less data are available concerning the clinical impact of those differences. Study Design and Methods The effects of two types of RCC (RCC‐A, RCC‐B) on transfusion regime were compared in a non‐blinded ...
Maria Rita Gamberini   +15 more
wiley   +1 more source

Selecting β‐thalassemia Patients for Gene Therapy: A Decision‐making Algorithm

open access: yesHemaSphere, Volume 5, Issue 5, May 2021., 2021
This expert opinion originally developed by a panel of the Italian Society of Thalassemias and Hemoglobinopathies (SITE), reviewed and adopted by the European Hematology Association (EHA) through the EHA Scientific Working Group on Red Cells and Iron, has been developed as priority decision‐making algorithm on evidence and consensus with the aim to ...
Donatella Baronciani   +13 more
wiley   +1 more source

Bronquite plástica em criança com talassemia alfa Plastic bronchitis in a child with thalassemia alpha

open access: yesJornal de Pediatria, 2005
OBJETIVO: A bronquite plástica é uma doença infreqüente na criança, sendo caracterizada por moldes ou cilindros mucofibrinosos na árvore traqueobrônquica.
Tiago N. Veras   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy